3644 results for «2753»

Filter By

3644 results

Complications in complex rotational atherectomy

This session will help you get prepared if you have to become familiar with a novel way to release stuck rotational atherectomy burr, deal with severely calcified RCA including removal of a stuck Rotablator, or cope when Rotablator burr catheter entraps.

EuroPCR 2021 Complications in complex rotational atherectomy

EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in BRS/BVS:

  • Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
  • France Absorb registry: final five years follow-up
  • A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
  • Three-year follow-up of the prospective bvs stemi strategy-it study
  • Final five-year results of AIDA trial
  • Bioresorbable...
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22

Empowering DES performance in complex patients to maximise efficacy and safety outcomes

20 May 2021 – From EuroPCR 2021

Watch this session presented by Marco Valgimigli, Istvan Ferenc Edes, Antonio Colombo, Rafael Romaguera, Gennaro Sardella and Pieter Stella in order to identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients, to understand how re-PCI impacts...

Empowering DES performance in complex patients to maximise efficacy and safety outcomes

EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in drugs & devices:

  • POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
  • CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
  • PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

The new Evolut PRO+ system: optimal procedural outcomes in all patients

20 May 2021 – From EuroPCR 2021

Watch this session presented by Didier Tchetche, Jean Fajadet, Azeem Latib, Anna Sonia Petronio, Daniel Blackman and Tanja Rudolph in order to explore benefits of the new Evolut PRO+ system and its versatility to treat different patient anatomies, to understand how the cusp overlap and commissural alignment techniques can...

The new Evolut PRO+ system: optimal procedural outcomes in all patients

Improving personalised vascular care using novel technologies: how can I start?

19 May 2021 – From EuroPCR 2021

Watch this session presented by Salvatore Brugaletta, Nick West, Rasha Al-Lamee, Will Davies, Angela H.E.M. Maas and William Wijns in order to learn more about personalised vascular healthcare, to understand the value of personalised vascular healthcare, and to see practical examples on how this can be implemented in your practice.

Improving personalised vascular care using novel technologies: how can I start?

Coronary access after TAVI, a growing need

20 May 2021 – From EuroPCR 2021

Watch this session presented by Nicolas Van Mieghem, Christopher Meduri, Andreas Ruck, Nawzad Saleh, Joanna Wykrzykowska and Mohamed Abdel-Wahab in order to learn about the growing importance of coronary access after TAVI, to understand how TAVI design and implantation technique has an impact on future coronary access, and to discuss the...

Coronary access after TAVI, a growing need

Redefining hypertension management with renal denervation

19 May 2021 – From EuroPCR 2021

Watch this session presented by Jeffrey Popma, David Kandzari, Felix Mahfoud and Andrew Sharp in order to understand the latest data on the safety and efficacy of radiofrequency renal denervation including future studies, to learn about the long-term durability of renal denervation in a real-world patient population, and...

Redefining hypertension management with renal denervation

Why physiology and co-reg is helpful in treating patients with multivessel disease/diffused disease

20 May 2021 – From EuroPCR 2021

Watch this session presented by Sukhjinder Nijjer, Nick Curzen, Rasha Al-Lamee and Sayan Sen in order to learn about the new pressure guide wire OmniWire and workflow enhancement with Azurion and IntraSight, to understand how "interventional physiology" can guide PCI in diffuse, multivessel coronary artery disease, and to learn how...

Why physiology and co-reg is helpful in treating patients with multivessel disease/diffused disease

Latest insights: when to choose orbital atherectomy

20 May 2021 – From EuroPCR 2021

Watch this session presented by Nicolas Van Mieghem, Surendra Avula and Ajay Kirtane in order to understand the challenges of treating severe calcium, to know about the OAS overview with dual-action MOA technology and the clinical evidence supporting its use, and to be introduced to treatment technique.

Latest insights: when to choose orbital atherectomy

Sustained Limus release, redefining indications for drug-eluting balloons

20 May 2021 – From EuroPCR 2021

Watch this session presented by Bernardo Cortese, Kambis Mashayekhi, Jonas Häner and Tuomas Rissanen in order to understand how sustained Limus release technology can broaden DEB indications, to learn how SELUTION SLR sustained Limus DEB performs in daily clinical practice, and to know more about the importance of sustained Limus release technology...

Sustained Limus release, redefining indications for drug-eluting balloons

Multivessel disease revascularisation: balancing the risk

19 May 2021 – From EuroPCR 2021

Watch this session presented by Jean Fajadet, Thomas Cuisset, Bruno Farah, Marek Grygier, Maciej Lesiak and Sylwia Iwanczyk in order to understand the selection of PCI for multivessel disease patients, to demonstrate the best treatment strategy for patients presenting with multivessel disease, and to discuss DAPT strategy in multivessel...

Multivessel disease revascularisation: balancing the risk

Challenges and opportunities in high-risk patients undergoing TAVI

19 May 2021 – From EuroPCR 2021

Watch this session presented by Marco Valgimigli, Raul Moreno and Peter Nordbeck in order to discuss the designing TAVI trial for high-risk patients, the timing of TAVI and PCI, as well as the balance between thrombosis prevention and bleeding mitigation

Challenges and opportunities in high-risk patients undergoing TAVI

EuroPCR 2021 - Innovations in peripheral and structural interventions

18 May 2021 – From EuroPCR 2021

In this session, discover how an effective calcium debridement procedure in stenotic aortic valves may restore the valve function, and why biometric indicators and engineering characteristics are so important for effective and safe delivery of endovascular care.

EuroPCR 2021 - Innovations in peripheral and structural interventions

EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in bifurcation lesions:

  • EBC MAIN - the European Bifurcation Club Left Main Coronary Bifurcation Study
  • Clinical Outcomes after Physiology-Guided Treatment of Coronary Bifurcations
EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!

MagicTouch sirolimus coated balloon continues to be the choice of treatment for CAD

19 May 2021 – From EuroPCR 2021

Watch this session presented by Antonio Colombo, Aloke Finn, Sandeep Basavarajaiah, Gianluca Caiazzo and Bernardo Cortese in order to know where to use a DCB in today's clinical practice, to learn about real-world case-based experience and interesting data presentation from various registries and clinical studies, and to understand the technology...

MagicTouch sirolimus coated balloon continues to be the choice of treatment for CAD

Advancing solutions for tricuspid regurgitation patients: introducing TriClip G4

19 May 2021 – From EuroPCR 2021

Watch this session presented by Francesco Maisano, Philipp Lurz, Fabien Praz, Patrizio Lancellotti  and Georg Nickenig in order to learn about patient diagnosis and selection for tricuspid transcatheter treatment with TriClip, about latest clinical data supporting TriClip therapy, and about real life experience and attest product innovation: TriClip G4.

Advancing solutions for tricuspid regurgitation patients: introducing TriClip G4

TAVI in a patient with coronary artery disease - Session with LIVE demonstration

18 May 2021 – From EuroPCR 2021

Watch this session if you want to discuss the available data for treating coronary artery disease in patients undergoing TAVI and to understand the role of FFR/IFR in coronary artery disease assessment prior to TAVI.

This session was originally presented during EuroPCR 2021.

TAVI in a patient with coronary artery disease

Treatment of small vessel disease - To stent or not to stent?

07 Oct 2022 – From AICT-AsiaPCR 2022

Consult this session if you want to learn the tips and tricks to perform a small vessel disease intervention and to discuss the pros and cons of treating small vessel disease with DCB and/or DES.

Treatment of small vessel disease - To stent or not to stent?

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

07 Oct 2022 – From AICT-ASIAPCR 2022

Consult this session to understand the technology and scientific evidence of the novel sirolimus drug-coated balloon, to learn its utility for PCI in a variety of lesion and patient subsets and to understand the evidence and outcomes in real-world patients.

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment
Didn’t find what you were looking for?